Fusiderm B
indicated to support skin healing in inflammatory conditions complicated by infection.
Strengths: 2/0.12%
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Fucibet; Betamethasone and Fusidic Acid Cream
- Therapeutic class
Topical Corticosteroid/Antibiotic
- Pharmacological class
Corticosteroid; Fusidane Antibacterial
- Minor side effects
skin irritation; burning sensation
- Moderate side effects
contact dermatitis; skin thinning
- Dosage forms
Cream
- Administration route
Cutaneous use
- Prescription status
POM
- Manufacturer
Alkem Laboratories
- Onset Time
1–2 days
- Duration
up to 2 weeks
- Storage instructions
Store below 25°C.
- Age restrictions
Use with caution in children.
Contraindications
hypersensitivity to ingredients; fungal skin infections; tuberculosis of the skin
Precautions and warnings
avoid contact with eyes; use for shortest duration possible; discontinue if irritation occurs
Serious side effects
systemic absorption — requires immediate medical attention; adrenal suppression — requires immediate medical attention
Patient summary
indicated to support skin healing in inflammatory conditions complicated by infection.
Mechanism of action
This combination contains an antibiotic that inhibits bacterial protein synthesis and a potent corticosteroid that reduces inflammation, redness, and itching associated with various dermatological conditions.
Pregnancy and breastfeeding
Pregnancy: Consult a physician before use. Breastfeeding: Apply sparingly and avoid contact with breast skin.
Fusiderm B
indicated to support skin healing in inflammatory conditions complicated by infection.
Editorial Notes
- Active ingredient(s): Betamethasone, Fusidic Acid
- Listed indication(s): Eczema, Dermatitis